Differentiating scleroderma renal crisis from other causes of thrombotic microangiopathy in a postpartum patient

Clinical Nephrology

Volumn 80, Issue 4, 2013, Pages 293-297

  Abudiab, Muaz M ^a   Krause, Megan L ^a   Fidler, Mary E ^a   Nath, Karl A ^a   Norby, Suzanne M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Mixed connective tissue disease; Postpartum; Scleroderma; Thrombotic microangiopathy

Indexed keywords

AMLODIPINE; CAPTOPRIL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HAPTOGLOBIN; LACTATE DEHYDROGENASE; METOPROLOL; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE KIDNEY FAILURE; ADULT; APHASIA; ARTICLE; CASE REPORT; FEMALE; FEVER; FOLLOW UP; HEMOLYTIC ANEMIA; HUMAN; KIDNEY BIOPSY; LACTATE DEHYDROGENASE BLOOD LEVEL; MALAISE; PLASMAPHERESIS; RENAL REPLACEMENT THERAPY; SCLERODERMA RENAL CRISIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ACUTE KIDNEY INJURY; ADULT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; PLASMA EXCHANGE; POSTPARTUM PERIOD; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RENAL DIALYSIS; SCLERODERMA, SYSTEMIC;

EID: 84884967955     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107465     Document Type: Article

References (34)

1. Verbeke L, Delforge M, Dierickx D. Current insight into thrombotic thrombocytopenic purpura. Blood Coagul Fibrinolysis. 2010; 21: 3-10. doi:10.1097/MBC.0b013e32833335eb
2. Kiss JE. Thrombotic thrombocytopenic purpura: recognition and management. Int J Hematol. 2010; 91: 36-45. doi:10.1007/s12185-009-0478-z
3. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome. N Engl J Med. 1998; 339: 1578-1584. doi:10.1056/NEJM199811263392202
4. Rosales A, Riedl M, Zimmerhackl LB. Thrombotic microangiopathy: atypical HUS: current diagnostic and therapeutic approaches. Nat Rev Nephrol. 2010; 6: 504-506. doi:10.1038/nrneph.2010.98
5. Benz K, Amann K. Thrombotic microangiopathy: new insights. Curr Opin Nephrol Hypertens. 2010; 19: 242-247. doi:10.1097/MNH.0b013e 32 83378f25
6. Denton CP, Lapadula G, Mouthon L, Müller-Ladner U. Renal complications and scleroderma renal crisis. Rheumatology (Oxford). 2009; 48 (Suppl 3): iii32-iii35. doi:10.1093/rheumatology/ken483
7. Bussone G, Bérezné A, Pestre V, Guillevin L, Mouthon L. The scleroderma kidney: progress in risk factors, therapy, and prevention. Curr Rheumatol Rep. 2011; 13: 37-43. doi:10.1007/s11926- 010-0145-7
8. Weinstein R. Hypocalcemic toxicity and atypical reactions in therapeutic plasma exchange. J Clin Apher. 2001; 16: 210-211. doi:10.1002/jca.10000
9. Manadan AM, Harris C, Block JA. Thrombotic thrombocytopenic purpura in the setting of systemic sclerosis. Semin Arthritis Rheum. 2005; 34: 683-688. doi:10.1016/j.semarthrit.2004.08.008
10. Andersen GN, Vasko J. Scleroderma renal crisis and concurrent isolated pulmonary hypertension in mixed connective tissue disease and overlap syndrome: report of two cases. Clin Rheumatol. 2002; 21: 164-169. doi:10.1007/s10067-002- 8276-5
11. Celikbilek M, Elsurer R, Afsar B, Ozdemir HB, Sezer S, Ozdemir NF. Mixed connective tissue disease: a case with scleroderma renal crisis following abortion. Clin Rheumatol. 2007; 26: 1545-1547. doi:10.1007/s10067-006-0442-8
12. Crapper RM, Dowling JP, Mackay IR, Whitworth JA. Acute scleroderma in stable mixed connective tissue disease: treatment by plasmapheresis. Aust N Z J Med. 1987; 17: 327-329. doi:10.11 11/j.1 445- 5994.1987.tb01237.x
13. Greenberg SA, Amato AA. Inflammatory myopathy associated with mixed connective tissue disease and scleroderma renal crisis. Muscle Nerve. 2001; 24: 1562-1566. doi:10.1002/mus.1184
14. Satoh K, Imai H, Yasuda T, Wakui H, Miura AB, Nakamoto Y. Sclerodermatous renal crisis in a patient with mixed connective tissue disease. Am J Kidney Dis. 1994; 24: 215-218.
15. Kanso AAHN, Badr KF. Microvascular and macrovascular diseases of the kidney. In: Brenner BM (ed). Brenner and Rector's The Kidney 8th Edition. Philadelphia, PA: Saunders Elsevier; 2007, chap 32.
16. Castellá M, Pujol M, Juliá A, Massague I, Bueno J, Ramón Grifols J, Puig L. Thrombotic thrombocytopenic purpura and pregnancy: a review of ten cases. Vox Sang. 2004; 87: 287-290. doi:10.1111/ j.1423-0410.2004.00560.x
17. D'Angelo A, Fattorini A, Crippa L. Thrombotic microangiopathy in pregnancy. Thromb Res. 2009; 123 (Suppl 2): S56-S62. doi:10.1016/ S0049-3848(09)70012-X
18. Just S. Methodologies and clinical utility of ADAMTS- 13 activity testing. Semin Thromb Hemost. 2010; 36: 82-90. doi:10.1055/s-0030- 1 248727
19. Steen VD. Scleroderma renal crisis. Rheum Dis Clin North Am. 2003; 29: 315-333. doi:10.1016/ S0889-857X(03)00016-4
20. Slobodin G, Rosner I, Rozenbaum M, Naschitz JE, Zuckerman E, Yeshurun D. Systemic sclerosis sine scleroderma: is it always the same disease? Report of three patients and discussion. Rheumatol Int. 2002; 22: 170-172. doi:10.1007/s00296- 002-0222-y
21. Szigeti N, Fábián G, Czirják L. Fatal scleroderma renal crisis caused by gastrointestinal bleeding in a patient with scleroderma, Sjögren's syndrome and primary biliary cirrhosis overlap. J Eur Acad Dermatol Venereol. 2002; 16: 276-279. doi:10.1046/j.1468-3083.2002.00441.x
22. Chakravarty EF. Vascular complications of systemic sclerosis during pregnancy. Int J Rheumatol, DOI 10.1155/2010/287248, , 2010. doi: 10.1155/2010/287248
23. Trang G et al. Corticosteroids and the risk of scleroderma renal crisis: a systematic review. Rheumatology international, 2010. doi: 1010.1007/s00296- 010-1697-6.
24. Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med. 1990; 113: 352-357.
25. Hagel S, Jantsch J, Budde U, Kalden JR, Eckardt KU, Veelken R. Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab. Thromb Haemost. 2008; 100: 151-153.
26. Gabbe SGNJ, Simpson JL ed. Obstetrics: Normal and Problem Pregnancies. Philadelphia, PA: Elsevier; 5th ed. 2005,
27. Fakhouri F, Frémeaux-Bacchi V. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura? Nat Clin Pract Nephrol. 2007; 3: 679-687. doi:10.1038/ncpneph0670
28. Espinosa G, Bucciarelli S, Cervera R, Lozano M, Reverter JC, de la Red G, Gil V, Ingelmo M, Font J, Asherson RA. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis. 2004; 63: 730-736. doi:10.1136/ard.2003.007245
29. Steen VD, Medsger TA Jr. Long-term outcomes of scleroderma renal crisis. Ann Intern Med. 2000; 133: 600-603.
30. Uthman I, Khamashta M. Antiphospholipid syndrome and the kidneys. Semin Arthritis Rheum. 2006; 35: 360-367. doi:10.1016/j.semarthr it.2006.01.001
31. Amirlak I, Amirlak B. Haemolytic uraemic syndrome: an overview. Nephrology (Carlton). 2006; 11: 213-218. doi:10.1111/j.1440-1797.2006.0 055 6.x
32. Conlon PJ et al. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/ hemolytic uremic syndrome in adults. Nephro Dial Transplant. 1995; 10: 1189-1193.
33. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008; 359: 800-809. doi:10.1056/NEJMoa0706790
34. Habli M et al. Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Am J Obstet Gynecol. 2009; 201: 385 e1-5.